Politicized Medicine Hindered Use of Ivermectin for COVID, according to the Journal of American Physicians and Surgeons
September 04, 2024 11:12 ET
|
Association of American Physicians and Surgeons
The politicized response to Covid included a war on the use of ivermectin. Studies have conflicting results. The issue is at a stalemate.
Repurposed Drugs Needed for COVID-19, according to Journal of American Physicians and Surgeons
June 06, 2024 13:45 ET
|
Association of American Physicians and Surgeons
A heavily politicized process suppressed the use of safe, affordable, repurposed drugs such as hydroxychoroquine for early treatment of COVID.
Infectious Disease Specialist Calls Campaign against Repurposed Drugs in COVID-19 a ‘Great Hypocrisy’
March 21, 2024 11:01 ET
|
Association of American Physicians and Surgeons
Evidence for benefit of hydroxychloroquine and other "off-label" drugs for COVID is hidden in plain sight, says infectious disease specialist.
US Alopecia Areata Market Forecast Shows Prominent Growth by 2032, with Emerging Treatment Landscape
January 24, 2024 10:53 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "US Alopecia Areata - Market Insight, Epidemiology And Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. The latest...
Accountability Needed for COVID Debacle, according to the Journal of American Physicians and Surgeons
December 13, 2023 11:51 ET
|
Association of American Physicians and Surgeons
Regulatory agencies and individuals, that have pervasive conflicts of interest, need to be held accountable for the disastrous COVID-19 response.
Global Global Antimalarial Drugs Market Research Report 2022: Increasing Prevalence of Malaria Coupled with Surge in Research for New Drugs to Propel Growth - Forecasts to 2028
February 17, 2023 06:48 ET
|
Research and Markets
Dublin, Feb. 17, 2023 (GLOBE NEWSWIRE) -- The "Global Antimalarial Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028: Segmented By Drug Type, By Drug Class, By...
Global Hydroxychloroquine Market Projected to Reach Over USD 2,598.6 Million by 2028 - Vantage Market Research
February 16, 2022 07:39 ET
|
Vantage Market Research
WASHINGTON, Feb. 16, 2022 (GLOBE NEWSWIRE) -- The Global Hydroxychloroquine Market size is expected to reach over USD 2,598.6 Million by 2028, exhibiting a Compound Annual Growth Rate (CAGR) of 5.7%...
The Worldwide Rheumatoid Arthritis Drugs Industry is Expected to Reach $34.3 Billion by 2027
January 28, 2022 05:03 ET
|
Research and Markets
Dublin, Jan. 28, 2022 (GLOBE NEWSWIRE) -- The "Rheumatoid Arthritis Drugs Market" report has been added to ResearchAndMarkets.com's offering. This report provides a detailed analysis of rheumatoid...
Hoarding by Government Continues While Expensive New Medications for Covid Are Unavailable, States the Association of American Physicians and Surgeons (AAPS)
January 17, 2022 13:54 ET
|
Association of American Physicians and Surgeons
TUCSON, Ariz., Jan. 17, 2022 (GLOBE NEWSWIRE) -- The Association of American Physicians and Surgeons (AAPS) condemns the continued hoarding by the federal government of hydroxychloroquine, which it...
Global Hydroxychloroquine Global Market Outlook 2021 to 2030: Key Players Include Bayer, Novartis, Mylan and Sanofi
December 30, 2021 06:08 ET
|
Research and Markets
Dublin, Dec. 30, 2021 (GLOBE NEWSWIRE) -- The "Hydroxychloroquine Global Market Report 2021: COVID-19 Implications and Growth to 2030" report has been added to ResearchAndMarkets.com's offering....